Search Result

Search Result
Business and Politics

BUSINESS: SPEAK MEMORY!

Monojit Lahiri dumps Bollywood and flashbacks into his life and times in the world of advertising.

Read More

Gender

GENDER: ZERO TOLERANCE TOWARDS SEXUAL HARASSMENT

Vinta Nanda in a conversation with General Secretary of CINTAA about what it takes to have zero tolerance for sexual harassmen...

Read More
Powerful People

THE COURAGE AND CONVICTION OF SAIF HYDER HASAN

After seeing the film YES PAPA, story of a victim of child sexual abuse at the hands of her father, Vinta Nanda has a conversa...

Read More
Thought Factory

IS DIGITAL TECHNOLOGY KILLING…INTIMACY??

Monojit Lahiri does a check out on how technology has impacted the idea of intimacy and the concept of interpersonal communica...

Read More
Kaleidoscope

AUTUMN BLOSSOMS: OF MOTHERHOOD & OTHER RELATIONSHIPS

The 50 stories in this collection, divided into three sections, deal with woman protagonists coping with the vagaries of relationships with men...

Read More
Thought Factory

BADHTI KA NAAM DADHI: THE NEW TREND OF FACE FUZZ!

Monojit Lahiri borrows the title of the genius Kishore Kumar’s goofy satire from the classic ‘Chalti Ka Naam Gaadi...

Read More
Trending

THE RECIPE FOR GOOD ROMANTIC COMEDY

The Ex Factor author Harini Srinivasan unpacks her views on the recipe for a good romantic comedy, the evolution of the genre over the yea...

Read More
Gender

WOMEN GATHER IN LARGE NUMBERS FOR THE FIRST NATIONAL MAHILA PANCHAYAT

Hundreds of women gathered to hold the first National Mahila Panchayat in solidarity with the struggling Wrestlers in Delhi on the 14th Read More

Trending

PAVING THE WAY FOR QUEER INCLUSION IN INDIAN WORKPLACES

Addressing LGBTQIA+ workplace discrimination through inclusive policies, Anurag Kundu, Chairperson DCPCR, launched 3 short films highlighting exclusion in workplaces, repor...

Read More
Health

XBB1.16 VARIANT– THE NEW SUPER SPREADER

Dr Kishore P Madhwani writes: India, in spite of  acquiring a high coverage of primary COVID vaccination (97%) and its second dose (90%), the precauti...

Read More